ChromoGenics receives a first order according to the new framework agreement with Humlegården Fastigheter.
In accordance with the recently signed framework agreement with Humlegården Fastigheter ChromoGenics received an order for Kv. Smultronet to a value of 420.000 SEK.
One part of the property has previously been upgraded with the product and with outstanding results regarding energy savings and comfort. Humlegården Fastigheter have now decided to continue the upgrade. This window upgrade is calculated to reduce the energy consumption from the replaced surfaces by -25%. Humlegården Fastigheter will by this create a positive environmental gain by reducing the Co2 emissions from the property by -6,500 kg/year.
“We are proud that Humlegården Fastigheter is choosing to continue to upgrade their property with ConverLight and we are looking forward to a successful co-operation moving forward. It is also great to be able to contribute to a better environment.”, says CEO Jerker Lundgren.
Jerker Lundgren, CEO Lars Ericsson, CFO and Head of Communications Tel: +46 (0)18 430 0430 E-mail: email@example.com Certified Adviser: G&W Fondkommission, e-mail: firstname.lastname@example.org, tel.: +46 (0) 8 503 000 50
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.
About ChromoGenics ChromoGenics offers dynamic glass with controllable heat- and light transmission and static glass with world leading performance. The company’s unique technology ConverLight® provides sustainable solar control for increased indoor comfort and energy efficiency. ConverLight also contributes to Green Building certifications. In 2016 the company started commercial sales to real estate projects in Scandinavia.
ChromoGenics is located in Uppsala, Sweden, and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. http://www.chromogenics.com